Nicole Lambert
Net worth: 1 M $ as of 2026-05-30
Net worth: 1 M $ as of 2026-05-30
Nicole Lambert is currently an Independent Director at Arcus Biosciences, Inc. since 2021 and President at Myriad Genetic Laboratories, Inc. Formerly, Ms. Lambert was Chief Operating Officer at Myriad Genetics, Inc. from 2022 to 2023.
Education includes undergraduate studies at Boston College and graduate studies at Icahn School of Medicine at Mount Sinai.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 43,000 ( 0.03% ) | 1 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Director/Board Member | 2021-08-02 |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | President | - |
| Companies | Position | End |
|---|---|---|
| MYRIAD GENETICS, INC. | Chief Operating Officer | 2023-10-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cancer predisposition testing services | Commercial Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions